Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT
Condition(s):Difference in the Change in Cardiovascular Risk in Treatment Resistant SchizophreniaLast Updated:July 20, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Difference in the Change in Cardiovascular Risk in Treatment Resistant SchizophreniaLast Updated:July 20, 2023Not yet recruiting
Condition(s):No Specific Condition (Patients Without Brugada Syndrome)Last Updated:February 23, 2022Unknown status
Condition(s):PCOSLast Updated:August 12, 2020Completed
Condition(s):Post-Traumatic Stress Disorder (PTSD)Last Updated:January 8, 2024Not yet recruiting
Condition(s):Soft Tissue AtrophyLast Updated:May 23, 2023Active, not recruiting
Condition(s):Idiopathic Restless Legs SyndromeLast Updated:July 2, 2014Completed
Condition(s):SchizophreniaLast Updated:February 6, 2018Completed
Condition(s):LeukemiaLast Updated:December 11, 2019Completed
Condition(s):Metabolic SyndromeLast Updated:December 20, 2023Recruiting
Condition(s):Obsessive Compulsive DisorderLast Updated:October 27, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.